Skip to main content
Menu Search & Directory

Featured Labs

Dr. Hoft Lab
 Dan Hoft, M.D., Ph.D. and students.

Valerio Rasi is a second year M.D./Ph.D. student. After joining Dan Hoft’s, M.D., Ph.D., lab in the summer of 2017, Valerio started his project studying the role of γ9δ2 T cell in protection against Mycobacterium tuberculosis, the etiology for tuberculosis (TB) infection and disease. Previous work in the lab has shown that γ9δ2 T cells secrete Granzyme A (GzmA) upon interaction with TB-infected macrophages, and this production of GzmA is a key protective mechanism leading to enhanced control of intracellular mycobacteria. Valerio is currently studying this interaction, determining the mechanistic details of how how infected macrophages exposed to GzmA better inhibit the growth of mycobacteria. Elucidation of this mechanism of inhibition could important for combating the current world’s TB epidemic, with one quarter of the world population latently infected with TB.

Other areas that Dr. Hoft’s lab is currently working on include:

  • γ9δ2 T cell TCR repertoire and transcriptomal analyses of samples collected from volunteers pre- and post-BCG vaccination, and from those latently infected with TB to determine potential protective patterns;
  • developing a human challenge model for the evaluation of new TB vaccines;
  • generation of T cell-targeted multi-epitope universal influenza vaccines designed to protect the global population from both seasonal and pandemic influenza strains;
  • studying the role of Th17 cells in the control and clearance of Trypanosoma cruzi, the causative agent of Chagas disease;
  • T cell epitope mapping the Zika genome using PBMC from patients infected with Zika virus to better inform iterative vaccine development.
Dr. Hawiger's Lab

 Daniel Hawiger, M.D., Ph.D. and students Andrew Jones and Jessica Bourque.

Dendritic cells (DCs) have crucial roles in priming effector T cells but DCs also have critical tolerogenic functions in the peripheral immune system, extending the maintenance of immune homeostasis and blocking autoimmune responses. However, broad tolerogenic functions of DCs including induction of peripheral regulatory T cells (pTreg cells) could hamper protective immune responses against some pathogens and tumors, whereas an inadvertent activation of autoregressive T cells in the presence of pro-inflammatory stimuli could lead to autoimmunity. Therefore the maintenance of immune homeostasis by DCs requires specific mechanisms that actively adjust T cell functions to promote tolerance while preserving an overall high plasticity of the immune responses.

(DCs with specialized tolerogenic functions are represented here as red flowers attracting naïve T cells depicted as green bees that can acquire regulatory functions, symbolized as purple halos. Trends in Immunology, 2017, Nov;38(11):793-804). 

To clarify the mechanisms by which DCs govern T cell tolerance in the context of autoimmune disorders such as multiple sclerosis (MS) but also other immune responses, studies in my laboratory are focused on the roles of specialized subsets of DCs and their specific functions in tolerance as well as the relevant molecular mechanisms induced by such DCs in T cells. Our work has elucidated the functions of specific immunomodulatory pathways, cell signaling regulators and transcription factors that establish tolerogenic outcomes of the interactions between T cells and DCs. 

Daniel Hawiger's, M.D., Ph.D. Research

Return to the M.D./Ph.D. Main Page